This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- EOD:
- early-onset disease
- GBS:
- group B Streptococcus
- Hib:
- Haemophilus influenzae type b
- HICs:
- high-income countries
- HIV:
- human immunodeficiency virus
- Ig:
- immunoglobulin
- LOD:
- late-onset disease
- LMICs:
- low-middle income countries
- LRTI:
- lower respiratory tract infection
- PCV:
- pneumococcal conjugate vaccine
- RSV:
- respiratory syncytial virus
- Tdap:
- tetanus-diphtheria-acellular pertussis
- TT:
- tetanus toxoid
Abstract
Newborns and infants are at risk for severe infections with some pathogens (eg, Bordetella pertussis, influenza, respiratory syncytial virus, group B Streptococcus) during early life. To decrease this window of high susceptibility to some infections during early life and protect young infants, vaccination in pregnancy against some vaccine-preventable diseases (eg, influenza, pertussis, tetanus) has been recommended in an increasing number of countries with notable success. In addition, recent advances have been made in developing vaccines for pregnant women with the aim of reducing the respiratory syncytial virus and group B Streptococcus burden in infancy. In this article, we review the vaccines currently recommended during pregnancy and their benefits to newborns and infants. We also discuss progress made in the development of other vaccines that are expected to be evaluated in pregnant women in the near future.
- Copyright © 2021 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.